21 May 2013
Keywords: ares-serono, announces, frone, efficacy, data, ms, become
Article | 14 November 1994
Ares-Serono has become the fourth company in recent weeks to release new
data on a multiple sclerosis drug, in this ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 November 1994
21 November 1994
20 May 2013
© 2013 thepharmaletter.com